Matias Jose Gabrielle, Jusue-Torres Ignacio, Martin Brendan, Bajaj Ankush, Borys Ewa, Melian Edward, Barton Kevin, Anderson Douglas E, Prabhu Vikram C
Stritch School of Medicine, Maywood, Illinois, United States.
Department of Neurological Surgery, Loyola University Medical Center, Maywood, Illinois, United States.
J Neurol Surg B Skull Base. 2019 Jun;80(3):287-294. doi: 10.1055/s-0038-1669387. Epub 2018 Sep 6.
Assess impact of K -67 labeling index (LI; K -67 LI) on risk of recurrence or progression of WHO grade I meningiomas. Retrospective study of adult patients who underwent resection of cranial base meningioma between 2004 and 2016. 272 patients fulfilled criteria for inclusion in the study. Average age was 61.8 years; 196 (72%) were females. Simpson's grade 1 resection was noted in 77 patients (32%), grade 2 in 39 (16%), grade 3 in 36 (15%), and grade 4 in 88 (37%). The K -67 LI was low (1-4%) in 214 (78.7%), intermediate (5-9%) in 44 (16.2%), and high (>10%) in 14 (5.2%). Median follow-up was 39 months (IQR: 16-71 months); 221 (87.1%) tumors remained stable or did not recur, 19 (7.4%) recurred, and 14 (5.5%) progressed. Compared with tumors with low K -67 LI, those with intermediate K -67 LI had 2.47 times (2.47 [1.09-5.59], = 0.03), and those with high K -67 LI had 3.38 times (3.38 [1.16-9.89], = 0.03) higher risk of recurrence or progression. Tumors with K -67 LI > 4% had a shorter time to recurrence or progression ( = 0.01). Recurrence or progression-free survival rates at 3, 5, and 10 years for tumors with low K -67 LI were 95%, 89%, and 75%, respectively; tumors with intermediate K -67 LI, 87%, 69%, and 52%, respectively; tumors with high K -67 LI, 78%, 49%, and 49%, respectively. Following surgical resection of a WHO grade I cranial base meningioma, K -67 LI > 4% may predict an increased risk of recurrence or progression of residual tumor.
评估Ki-67标记指数(LI;Ki-67 LI)对世界卫生组织I级脑膜瘤复发或进展风险的影响。对2004年至2016年间接受颅底脑膜瘤切除术的成年患者进行回顾性研究。272例患者符合纳入研究标准。平均年龄为61.8岁;196例(72%)为女性。77例(32%)患者为辛普森1级切除,39例(16%)为2级,36例(15%)为3级,88例(37%)为4级。214例(78.7%)患者的Ki-67 LI较低(1%-4%),44例(16.2%)为中等(5%-9%)水平,14例(5.2%)较高(>10%)。中位随访时间为39个月(四分位间距:16-71个月);221例(87.1%)肿瘤保持稳定或未复发,19例(7.4%)复发,14例(5.5%)进展。与Ki-67 LI较低的肿瘤相比,Ki-67 LI中等的肿瘤复发或进展风险高2.47倍(2.47 [1.09-5.59],P = 0.03),Ki-67 LI较高的肿瘤高3.38倍(3.38 [1.16-9.89],P = 0.03)。Ki-67 LI>4%的肿瘤复发或进展时间较短(P = 0.01)。Ki-67 LI较低的肿瘤在3年、5年和10年时的无复发或进展生存率分别为95%、89%和75%;Ki-67 LI中等的肿瘤分别为87%、69%和52%;Ki-67 LI较高的肿瘤分别为78%、49%和49%。在对世界卫生组织I级颅底脑膜瘤进行手术切除后,Ki-67 LI>4%可能预示残留肿瘤复发或进展风险增加。